haplox.cnBioTechFounded: 2014Funding to Date: $42.87MM
HaploX aims to integrate liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies to improve the management of cancer patients.
For more details on financing and valuation for HaploX, register or login.
Already registered? Click here to log in
To read this article and more news on HaploX, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.